VEGFA and VEGFR2 expression are significantly enhanced in the wall of VVs compared to normal veins, particularly in VVs complicated by thrombophlebitis50; interestingly, our Mendelian randomisation analysis found evidence for a causal role played by VVs in thrombophlebitis risk. The gene discussed is VEGFA; the disease is Thrombophlebitis.